Published in Vaccine on January 13, 2006
The immunobiology of prion diseases. Nat Rev Immunol (2013) 1.13
High titers of mucosal and systemic anti-PrP antibodies abrogate oral prion infection in mucosal-vaccinated mice. Neuroscience (2008) 0.98
Immunotherapy in prion disease. Nat Rev Neurol (2012) 0.86
Toxic effects of intracerebral PrP antibody administration during the course of BSE infection in mice. Prion (2007) 0.78
Dendritic cell-mediated-immunization with xenogenic PrP and adenoviral vectors breaks tolerance and prolongs mice survival against experimental scrapie. PLoS One (2009) 0.78
Prion protein-specific antibodies-development, modes of action and therapeutics application. Viruses (2014) 0.78
VEGF: a modifier of the del22q11 (DiGeorge) syndrome? Nat Med (2003) 1.79
Reduced Treg frequency in LFA-1-deficient mice allows enhanced T effector differentiation and pathology in EAE. Eur J Immunol (2010) 1.58
Lithium induces clearance of protease resistant prion protein in prion-infected cells by induction of autophagy. J Neurochem (2009) 1.50
Autophagy induction by trehalose counteracts cellular prion infection. Autophagy (2009) 1.46
Disparate evolution of prion protein domains and the distinct origin of Doppel- and prion-related loci revealed by fish-to-mammal comparisons. FASEB J (2005) 1.29
Formation of critical oligomers is a key event during conformational transition of recombinant syrian hamster prion protein. J Biol Chem (2003) 1.29
Association of Bcl-2 with misfolded prion protein is linked to the toxic potential of cytosolic PrP. Mol Biol Cell (2006) 1.25
Gene expression profiling of scrapie-infected brain tissue. Biochem Biophys Res Commun (2004) 1.24
Quality of blood culture testing - a survey in intensive care units and microbiological laboratories across four European countries. Crit Care (2013) 1.19
Role of interleukin-1 in prion disease-associated astrocyte activation. Am J Pathol (2004) 1.13
Falciparum malaria after splenectomy: a prospective controlled study of 33 previously splenectomized Malawian adults. Trans R Soc Trop Med Hyg (2005) 1.11
Green tea extracts interfere with the stress-protective activity of PrP and the formation of PrP. J Neurochem (2008) 1.04
Immunisation with a synthetic prion protein-derived peptide prolongs survival times of mice orally exposed to the scrapie agent. Neurosci Lett (2003) 1.02
Increased frequency of EBV-specific effector memory CD8+ T cells correlates with higher viral load in rheumatoid arthritis. J Immunol (2008) 1.02
Association of SGK1 gene polymorphisms with type 2 diabetes. Cell Physiol Biochem (2008) 0.98
Simvastatin prolongs survival times in prion infections of the central nervous system. Biochem Biophys Res Commun (2006) 0.97
Diagnosis of acute Q fever with emphasis on enzyme-linked immunosorbent assay and nested polymerase chain reaction regarding the time of serum collection. Diagn Microbiol Infect Dis (2010) 0.95
Caspase-1-processed interleukins in hyperoxia-induced cell death in the developing brain. Ann Neurol (2005) 0.93
Accelerated prion replication in, but prolonged survival times of, prion-infected CXCR3-/- mice. J Virol (2008) 0.92
Role of cytokines and chemokines in prion infections of the central nervous system. Int J Dev Neurosci (2004) 0.92
Prion protein-related proteins from zebrafish are complex glycosylated and contain a glycosylphosphatidylinositol anchor. Biochem Biophys Res Commun (2006) 0.92
Glial fibrillary acidic protein and protein S-100B: different concentration pattern of glial proteins in cerebrospinal fluid of patients with Alzheimer's disease and Creutzfeldt-Jakob disease. J Alzheimers Dis (2009) 0.88
Rapid disease development in scrapie-infected mice deficient for CD40 ligand. EMBO Rep (2004) 0.87
Influence of targeting ligand flexibility on receptor binding of particulate drug delivery systems. Bioconjug Chem (2003) 0.87
Effectance and control as determinants of video game enjoyment. Cyberpsychol Behav (2007) 0.85
Maternofetal consequences of Coxiella burnetii infection in pregnancy: a case series of two outbreaks. BMC Infect Dis (2012) 0.84
Identification of cDNAs from Japanese pufferfish (Fugu rubripes) and Atlantic salmon (Salmo salar) coding for homologues to tetrapod prion proteins. FEBS Lett (2003) 0.84
Probing PrPSc structure using chemical cross-linking and mass spectrometry: evidence of the proximity of Gly90 amino termini in the PrP 27-30 aggregate. Biochemistry (2005) 0.84
Neuroinflammation in prion diseases: concepts and targets for therapeutic intervention. CNS Neurol Disord Drug Targets (2009) 0.84
Impaired Pten expression in human malignant peripheral nerve sheath tumours. PLoS One (2012) 0.84
Potential of active and passive immunizations for the prevention and therapy of transmissible spongiform encephalopathies. Expert Rev Vaccines (2007) 0.83
Contribution of serum immunoglobulin transudate to the antibody immune status of murine intestinal secretions: influence of different sampling procedures. Clin Diagn Lab Immunol (2003) 0.83
Stimulation of plasminogen activation by recombinant cellular prion protein is conserved in the NH2-terminal fragment PrP23-110. Thromb Haemost (2003) 0.83
Role of galectin-3 in prion infections of the CNS. Biochem Biophys Res Commun (2007) 0.83
Evaluation of drugs for treatment of prion infections of the central nervous system. J Gen Virol (2008) 0.82
Both lysine-clusters of the NH2-terminal prion-protein fragment PrP23-110 are essential for t-PA mediated plasminogen activation. Thromb Haemost (2004) 0.82
Rapid profiling of peptide stability in proteolytic environments. Anal Chem (2009) 0.80
Quantitation of major protein constituents of murine intestinal fluid. Anal Biochem (2010) 0.79
Synthesis of a fluorescent ganglioside GM1 derivative and screening of a synthetic peptide library for GM1 binding sequence motifs. Bioconjug Chem (2007) 0.79
Prion disease development in slow Wallerian degeneration (Wld(S)) mice. Neurosci Lett (2009) 0.78
Bystander protein protects potential vaccine-targeting ligands against intestinal proteolysis. J Control Release (2009) 0.77
Characteristics of German hospitals adopting health IT systems - results from an empirical study. Stud Health Technol Inform (2011) 0.77
Aspects of risk assessment and risk management of nosocomial transmission of classical and variant Creutzfeldt-Jakob disease with special attention to German regulations. Contrib Microbiol (2004) 0.77
Unchanged scrapie pathology in brain tissue of tyrosine kinase Fyn-deficient mice. Neurodegener Dis (2004) 0.77
A priori selection of the mobile and stationary phase in centrifugal partition chromatography and counter-current chromatography. J Chromatogr A (2012) 0.76
Study of the separation limits of continuous solid support free liquid-liquid chromatography: separation of capsaicin and dihydrocapsaicin by centrifugal partition chromatography. J Chromatogr A (2013) 0.76
The heat shock response is modulated by and interferes with toxic effects of scrapie prion protein and amyloid β. J Biol Chem (2012) 0.75
Correction: Risk Factors for Multi-Drug Resistant Pathogens and Failure of Empiric First-Line Therapy in Acute Cholangitis. PLoS One (2017) 0.75
Molecular evolution of peptide ligands with custom-tailored characteristics for targeting of glycostructures. PLoS Comput Biol (2012) 0.75
Biology of infectious proteins: lessons from yeast prions. Lancet (2004) 0.75
Vaccines against transmissible spongiform encephalopathies: an urgent need? Hum Vaccin (2007) 0.75
Development of an epitope-specific analytical tool for the major peanut allergen Ara h 2 using a high-density multiple-antigenic peptide strategy. Mol Nutr Food Res (2004) 0.75
[61-year old woman with unclear neurologic result]. Dtsch Med Wochenschr (2016) 0.75
Prion protein 90-231 contains a streptavidin-binding motif. Biochem Biophys Res Commun (2006) 0.75
Pushing antibody-based labeling systems to higher sensitivity by linker-assisted affinity enhancement. Bioconjug Chem (2011) 0.75
Biolabeling with 2,4-dichlorophenoxyacetic acid derivatives: the 2,4-D tag. Anal Chem (2009) 0.75
3-Methyl-4-chlorophenol for prion decontamination of medical devices. Infect Control Hosp Epidemiol (2006) 0.75